These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 7414765)

  • 21. [Magnesium excretion in recurrent calcium urolithiasis].
    Pfab R; Hegemann M; Schütz W; Böttger I
    Urologe A; 1985 Sep; 24(5):296-8. PubMed ID: 4060380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Influence of urinary citrate levels on spontaneous calcium oxalate dihydrate crystalluria].
    Hassani MA; Hennequin C; Lacour B; Daudon M
    Prog Urol; 2005 Sep; 15(4):650-5. PubMed ID: 16459680
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Identification of lithogenic risk factors by a simplified first-line laboratory assessment in urinary calculi patients].
    Glémain P; Prunet D
    Prog Urol; 2006 Nov; 16(5):542-5. PubMed ID: 17175947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Causes of hypocitraturia in recurrent calcium stone formers: focusing on urinary potassium excretion.
    Domrongkitchaiporn S; Stitchantrakul W; Kochakarn W
    Am J Kidney Dis; 2006 Oct; 48(4):546-54. PubMed ID: 16997050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calcium-to-Citrate Ratio Distinguishes Solitary and Recurrent Urinary Stone Forming Children.
    DeFoor W; Jackson E; Schulte M; Alam Z; Asplin J
    J Urol; 2017 Aug; 198(2):416-421. PubMed ID: 28365270
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urinary metabolic evaluations in normal and stone forming children.
    DeFoor W; Asplin J; Jackson E; Jackson C; Reddy P; Sheldon C; Erhard M; Minevich E
    J Urol; 2006 Oct; 176(4 Pt 2):1793-6. PubMed ID: 16945651
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Crystalline aggregation in vitro: interaction between urinary macromolecules and the micromolecular environment.
    Guerra A; Meschi T; Schianchi T; Allegri F; Novarini A; Borghi L
    Acta Biomed; 2002; 73(1-2):11-26. PubMed ID: 12233273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of oral calcium loading on intact PTH and calcitriol in idiopathic renal calcium stone formers and healthy controls.
    Hess B; Lippuner K; Takkinen R; Villiger L; Ackermann D; Jaeger P
    Nephrol Dial Transplant; 1995; 10(9):1614-9. PubMed ID: 8559479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urinary citrate, bone resorption and intestinal alkali absorption in stone formers with fasting hypercalciuria.
    Messa P; Mioni G; Paganin L; Cruciatti A; Greco PL; Turrin D
    Scanning Microsc; 1994; 8(3):531-8; discussion 538-9. PubMed ID: 7747155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of indapamide on urinary calcium excretion in patients with and without urinary stone disease.
    Ceylan K; Topal C; Erkoc R; Sayarlioglu H; Can S; Yilmaz Y; Dogan E; Algun E; Gonulalan H
    Ann Pharmacother; 2005 Jun; 39(6):1034-8. PubMed ID: 15840731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanism of hypercalciuria in experimental metabolic acidosis.
    Marya RK; Dadoo RC; Khurana S; Keshwani RK; Chhabra HL
    Indian J Physiol Pharmacol; 1980; 24(4):341-5. PubMed ID: 7216389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of urinary proteins in calcium stone formers and healthy individuals: a case-control study.
    Pourmand G; Nasseh H; Sarrafnejad A; Mojtahedi A; Mehrsai A; Alamdari DH; Nourijelyani K
    Urol Int; 2006; 76(2):163-8. PubMed ID: 16493220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spherical calcium bodies in stone-forming urine.
    Resnick MI; Boyce WH
    Invest Urol; 1978 May; 15(6):449-51. PubMed ID: 649292
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urinary citrate excretion in stone-formers and normal controls.
    Welshman SG; McGeown MG
    Br J Urol; 1976 Feb; 48(1):7-11. PubMed ID: 1268467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The role of urine pH in the occurrence of phosphaturia].
    Tozuka K; Hara Y; Moriguchi H; Kikuchi T; Tokue A
    Hinyokika Kiyo; 1989 Sep; 35(9):1475-8. PubMed ID: 2816612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Exaggerated calciuric response to an acute acid load in patients forming renal calcium stones].
    Normand M; Cayotte JL; Houillier P; Peuchant A; Paillard M
    Nephrologie; 1993; 14(6):283-5. PubMed ID: 8145886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Urinary oxalate in recurrent calcium urolithiasis with and without hyperfunctioning parathyroid glands and in healthy controls. influence of age and season (author's transl)].
    Schwille PO; Paulus M; Scholz D; Sigel A; Wilhelm E
    Urologe A; 1979 Jul; 18(4):215-24. PubMed ID: 473457
    [No Abstract]   [Full Text] [Related]  

  • 38. Renal phosphate control as a reliable predictive factor of stone recurrence.
    Kim YJ; Kim TH; Yun SJ; Kim ME; Kim WJ; Lee SC
    J Urol; 2009 Jun; 181(6):2566-72; discussion 2572. PubMed ID: 19375105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Compared metabolic effects of phosphorus or hydrochlorothiazide therapy in hypercalciuric stone-formers (author's transl)].
    Dard S; Ulmann A
    Nephrologie; 1981; 2(1):4-7. PubMed ID: 7345375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantification of osteopontin in the urine of healthy and stone-forming men.
    Yasui T; Fujita K; Hayashi Y; Ueda K; Kon S; Maeda M; Uede T; Kohri K
    Urol Res; 1999 Aug; 27(4):225-30. PubMed ID: 10460890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.